Clinical Trials in Roma, Roma
1 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer)
Revolution Medicines, Inc.420 enrolled129 locationsNCT06881784
Recruiting
Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament115 enrolled71 locationsNCT03394365
Recruiting
Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
Istituto Clinico Humanitas150 enrolled11 locationsNCT07401615
Recruiting
stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective Database
Breast CancerOligometastasis
Istituto Clinico Humanitas300 enrolled28 locationsNCT07397585
Recruiting
Phase 2
Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients
European Institute of Oncology45 enrolled5 locationsNCT06690840
Recruiting
Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
Breast Cancer
National Cancer Institute, Naples300 enrolled2 locationsNCT05817227
Recruiting
Not Applicable
Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery
Breast Neoplasms
Fondazione Policlinico Universitario Campus Bio-Medico50 enrolled1 locationNCT06608446
Recruiting
A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer
Breast Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology1,500 enrolled10 locationsNCT04625023
Recruiting
Phase 2
NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer
Breast Cancer
Fondazione Oncotech51 enrolled8 locationsNCT06259929